Cellular distribution of injected PLGA-nanoparticles in the liver

Jin Kyu Park, Teruo Utsumi, Young Eun Seo, Yang Deng, Ayano Satoh, William Mark Saltzman, Yasuko Iwakiri

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

The cellular fate of nanoparticles in the liver is not fully understood. Because the effectiveness and safety of nanoparticles in liver therapy depends on targeting nanoparticles to the right cell populations, this study aimed to determine a relative distribution of PLGA-nanoparticles (sizes 271±1.4 nm) among liver cells in vivo. We found that Kupffer cells were the major cells that took up nanoparticles, followed by liver sinusoidal endothelial cells and hepatic stellate cells. Nanoparticles were found in only 7% of hepatocytes. Depletion of Kupffer cells by clodronate liposomes increased nanoparticle retention in liver sinusoidal endothelial cells and hepatic stellate cells, but not in hepatocytes. It is importantly suggested that studies of drug-loaded nanoparticle delivery to the liver have to demonstrate not only uptake of nanoparticles by the target cell type but also non-uptake by other cell types to assess their effect as well as ensure their safety.

Original languageEnglish
Pages (from-to)1365-1374
Number of pages10
JournalNanomedicine: Nanotechnology, Biology, and Medicine
Volume12
Issue number5
DOIs
Publication statusPublished - Jul 1 2016

Fingerprint

Liver
Nanoparticles
Hepatic Stellate Cells
Kupffer Cells
Endothelial cells
Hepatocytes
Endothelial Cells
Clodronic Acid
Safety
polylactic acid-polyglycolic acid copolymer
Liposomes
Cells
Pharmaceutical Preparations
Population

Keywords

  • Hepatic stellate cells
  • Hepatocytes
  • Kupffer cells
  • Liver sinusoidal endothelial cells
  • Nanomedicine

ASJC Scopus subject areas

  • Molecular Medicine
  • Bioengineering
  • Biomedical Engineering
  • Materials Science(all)
  • Medicine (miscellaneous)
  • Pharmaceutical Science

Cite this

Cellular distribution of injected PLGA-nanoparticles in the liver. / Park, Jin Kyu; Utsumi, Teruo; Seo, Young Eun; Deng, Yang; Satoh, Ayano; Saltzman, William Mark; Iwakiri, Yasuko.

In: Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 12, No. 5, 01.07.2016, p. 1365-1374.

Research output: Contribution to journalArticle

Park, Jin Kyu ; Utsumi, Teruo ; Seo, Young Eun ; Deng, Yang ; Satoh, Ayano ; Saltzman, William Mark ; Iwakiri, Yasuko. / Cellular distribution of injected PLGA-nanoparticles in the liver. In: Nanomedicine: Nanotechnology, Biology, and Medicine. 2016 ; Vol. 12, No. 5. pp. 1365-1374.
@article{6e99619fdba342d09a91f8a478f96340,
title = "Cellular distribution of injected PLGA-nanoparticles in the liver",
abstract = "The cellular fate of nanoparticles in the liver is not fully understood. Because the effectiveness and safety of nanoparticles in liver therapy depends on targeting nanoparticles to the right cell populations, this study aimed to determine a relative distribution of PLGA-nanoparticles (sizes 271±1.4 nm) among liver cells in vivo. We found that Kupffer cells were the major cells that took up nanoparticles, followed by liver sinusoidal endothelial cells and hepatic stellate cells. Nanoparticles were found in only 7{\%} of hepatocytes. Depletion of Kupffer cells by clodronate liposomes increased nanoparticle retention in liver sinusoidal endothelial cells and hepatic stellate cells, but not in hepatocytes. It is importantly suggested that studies of drug-loaded nanoparticle delivery to the liver have to demonstrate not only uptake of nanoparticles by the target cell type but also non-uptake by other cell types to assess their effect as well as ensure their safety.",
keywords = "Hepatic stellate cells, Hepatocytes, Kupffer cells, Liver sinusoidal endothelial cells, Nanomedicine",
author = "Park, {Jin Kyu} and Teruo Utsumi and Seo, {Young Eun} and Yang Deng and Ayano Satoh and Saltzman, {William Mark} and Yasuko Iwakiri",
year = "2016",
month = "7",
day = "1",
doi = "10.1016/j.nano.2016.01.013",
language = "English",
volume = "12",
pages = "1365--1374",
journal = "Nanomedicine: Nanotechnology, Biology, and Medicine",
issn = "1549-9634",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Cellular distribution of injected PLGA-nanoparticles in the liver

AU - Park, Jin Kyu

AU - Utsumi, Teruo

AU - Seo, Young Eun

AU - Deng, Yang

AU - Satoh, Ayano

AU - Saltzman, William Mark

AU - Iwakiri, Yasuko

PY - 2016/7/1

Y1 - 2016/7/1

N2 - The cellular fate of nanoparticles in the liver is not fully understood. Because the effectiveness and safety of nanoparticles in liver therapy depends on targeting nanoparticles to the right cell populations, this study aimed to determine a relative distribution of PLGA-nanoparticles (sizes 271±1.4 nm) among liver cells in vivo. We found that Kupffer cells were the major cells that took up nanoparticles, followed by liver sinusoidal endothelial cells and hepatic stellate cells. Nanoparticles were found in only 7% of hepatocytes. Depletion of Kupffer cells by clodronate liposomes increased nanoparticle retention in liver sinusoidal endothelial cells and hepatic stellate cells, but not in hepatocytes. It is importantly suggested that studies of drug-loaded nanoparticle delivery to the liver have to demonstrate not only uptake of nanoparticles by the target cell type but also non-uptake by other cell types to assess their effect as well as ensure their safety.

AB - The cellular fate of nanoparticles in the liver is not fully understood. Because the effectiveness and safety of nanoparticles in liver therapy depends on targeting nanoparticles to the right cell populations, this study aimed to determine a relative distribution of PLGA-nanoparticles (sizes 271±1.4 nm) among liver cells in vivo. We found that Kupffer cells were the major cells that took up nanoparticles, followed by liver sinusoidal endothelial cells and hepatic stellate cells. Nanoparticles were found in only 7% of hepatocytes. Depletion of Kupffer cells by clodronate liposomes increased nanoparticle retention in liver sinusoidal endothelial cells and hepatic stellate cells, but not in hepatocytes. It is importantly suggested that studies of drug-loaded nanoparticle delivery to the liver have to demonstrate not only uptake of nanoparticles by the target cell type but also non-uptake by other cell types to assess their effect as well as ensure their safety.

KW - Hepatic stellate cells

KW - Hepatocytes

KW - Kupffer cells

KW - Liver sinusoidal endothelial cells

KW - Nanomedicine

UR - http://www.scopus.com/inward/record.url?scp=84962195837&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962195837&partnerID=8YFLogxK

U2 - 10.1016/j.nano.2016.01.013

DO - 10.1016/j.nano.2016.01.013

M3 - Article

C2 - 26961463

AN - SCOPUS:84962195837

VL - 12

SP - 1365

EP - 1374

JO - Nanomedicine: Nanotechnology, Biology, and Medicine

JF - Nanomedicine: Nanotechnology, Biology, and Medicine

SN - 1549-9634

IS - 5

ER -